Resveratrol to Treat Sickle Cell Anemia and Thelassemia?

Resveratrol to Treat Sickle Cell Anemia and Thelassemia?

resveratrol red wine 600 apr 12.jpg

Research in the International Journal of Molecular Medicine has looked at how Resveratrol can help in the treatment of thalassemia and sickle-cell anemia.

These patients’ cells show signs of oxidative stress – which leads to chronic anemia – because of the abnormalities they experience in the production of haemoglobin.

The researchers, from the Hadassah-Hebrew University Medical Center, Jerusalem, the Biotechnology Centre, Ferrara, Italy, and the Department of Biology of Agricultural Plants, at the University of Pisa, wanted to identify compounds that exhibited antioxidant and hemoglobin-inducing activities.

The results show that Resveratrol fits the bill – and is believed to be useful for both activities – and could offer a simple and inexpensive treatment to thalassemia and sickle-cell anemia sufferrers.

New flu drug drives drug resistance in influenza viruses

New flu drug drives drug resistance in influenza viruses

A new study examined the effects of baloxavir treatment on
influenza virus samples that were collected from patients both

Plant based diet may reduce cardiovascular death risk by 32%

The faster you walk, the longer you may live


53.1% of office-based physicians in the United States, across specialty areas, recommended at least one complementary health approach (CHA) to their parents during the previous year.

Although most research on child sexual abuse survivors is focused on negative consequences, a new study has instead examined factors associated with resilience and flourishing among adult survivors.

Although holidays are meant to be a time of celebration and togetherness, they can have a negative impact on older adults who run a high risk of being socially isolated.

Investigators have discovered that eating a healthy diet may reduce the risk of acquired hearing loss.

The COMPLEMENTARY MEDICAL ASSOCIATION (The CMA) © 2012. No part of this site may be reproduced without the express permission of The Complementary Medical Association. If used without prior consent a charge of US $1,000 per article, or mini section is paid (US $50 per word (minimum) will be charged. This is not meant to reflect a commercial rate for the content, but as a punitive cost and to reimburse The CMA for legal fees and time costs). Use of the contents, without permission will be taken as consent to bill the illegal user in full.